![](/img/cover-not-exists.png)
Cabozantinib (CABO) plus durvalumab (DURVA) in patients with advanced and chemotherapy-treated bladder carcinoma, of urothelial and non-urothelial histology: The open-label, single-arm, phase 2 ARCADIA trial
Raggi, D., Giannatempo, P., Anichini, A., Calareso, G., Crippa, F., Mariani, L., Necchi, A.Volume:
17
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(18)31638-5
Date:
March, 2018
File:
PDF, 81 KB
english, 2018